The determinants of patentees' use of 'continuation' patent applications in the United States Patent and Trademark Office, 1980-99

被引:0
作者
Graham, Stuart J. H. [1 ]
机构
[1] Georgia Inst Technol, Coll Management, Atlanta, GA 30332 USA
来源
INTELLECTUAL PROPERTY RIGHTS: INNOVATION, GOVERNANCE AND THE INSTITUTIONAL ENVIRONMENT | 2006年
关键词
Patents; Submarine patents; Patent continuation applications; Intellectual property strategy;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
This chapter describes and examines the use of the 'continuation' patent application procedure available in the United States but not generally elsewhere in the world. The continuation procedure allows a US patent applicant to postpone the issue of a patent, affording inventors several strategic opportunities, among which are delay and secrecy. The chapter also demonstrates the perverse effects of so-called 'submarine patents', continuation patents that surface in a marketplace in which the patented technology has been widely embraced by adopters unaware that a valid patent was pending and hidden from view. In addition to examining several specific cases of submarine patents - cases in which the patentee was able to extract extraordinary economic rents - the chapter investigates through negative binomial regression the determinants of patentees' use of the continuation procedure. Continuations are shown to be significantly more likely when the resulting patent is held by an organization, is held by a domestic (US) entity, is comprised of more patent claims, or is drawn from a wider breadth of technologies. The chapter also examines how and why innovators in the semiconductor and pharmaceutical technologies have employed the continuation patent application procedure, demonstrating that in each of these important sectors the continuation procedure has been widely used, and may offer strategic benefits.
引用
收藏
页码:215 / 239
页数:25
相关论文
共 20 条
[1]  
Albright B, 2004, FRONTLINE SOLUT 0127, P1
[2]  
[Anonymous], 1976, INNOVATION PHARM IND
[3]  
Burchfiel K, 1995, J PATENT TRADEMARK O, V77, P222
[4]  
Cohen W.M., 2000, 7552 NBER
[5]  
COMANOR WS, 1986, J ECON LIT, V24, P1178
[6]  
GRABOWSKI H, 1983, REGULATION PHARM BAL
[7]  
Grabowski H. G., 1976, DRUG REGULATION INNO
[8]  
Graham S., 2004, EC INNOVATION NEW TE, V13, P443
[9]  
Graham S. J. H., 2004, CONTINUATION COMPLEM
[10]  
Hall B. H., 2000, 7741 NBER